Your account is not claimed yet. You can sign up with ORCID to claim your account.

William R Jacobs

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 19

Top Venues

Journal of bacteriology

Proceedings of the National Academy of Sciences of the United States of America

Antimicrobial agents and chemotherapy

mBio

Albert Einstein College of Medicine

University of Alabama at Birmingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Albert Einstein College of Medicine Jul 1o 1996

United States

Professor :: Molecular Genetics

Education History

University of Alabama at Birmingham Aug 1o 1979 - Jun 30o 1985

United States

PHD :: Molecular Cell Biology

Publications

Ian L Sparks, Keith M Derbyshire, William R Jacobs, Yasu S Morita
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. Journal of bacteriology 205 (1) (2023)
Ian L Sparks, Keith M Derbyshire, William R Jacobs, Yasu S Morita
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. Journal of bacteriology 205 (1) (2023)
Ian L Sparks, Keith M Derbyshire, William R Jacobs, Yasu S Morita
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. Journal of bacteriology 205 (1) (2023)
Ian L Sparks, Keith M Derbyshire, William R Jacobs, Yasu S Morita
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. Journal of bacteriology 205 (1) (2023)
Sushil Pandey, Catherine Vilchèze, Jim Werngren, Arnold Bainomugisa, Mikael Mansjö, Ramona Groenheit, Paolo Miotto, Daniela Maria Cirillo, Christopher Coulter, Alain R Baulard, Thomas Schön, William R Jacobs, Kamel Djaout, Claudio Umberto Köser
Loss-of-function mutations in ndh do not confer delamanid, ethionamide, isoniazid, or pretomanid resistance in Mycobacterium tuberculosis . Antimicrobial agents and chemotherapy (2023)
Ian L Sparks, Keith M Derbyshire, William R Jacobs, Yasu S Morita
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. Journal of bacteriology 205 (1) (2023)
Ian L Sparks, Keith M Derbyshire, William R Jacobs, Yasu S Morita
Mycobacterium smegmatis: The Vanguard of Mycobacterial Research. Journal of bacteriology (2023)
Rajagopalan Saranathan, Emmanuel Asare, Lawrence Leung, Anna Paula de Oliveira, Katherine E Kaugars, Claire V Mulholland, Regy Lukose, Michael Berney, William R Jacobs
Capturing Structural Variants of Herpes Simplex Virus Genome in Full Length by Oxford Nanopore Sequencing. Microbiology spectrum 10 (5) (2022)
Lin Wang, Emmanuel Asare, Amol C Shetty, Freddy Sanchez-Tumbaco, Megan R Edwards, Rajagopalan Saranathan, Brian Weinrick, Jiayong Xu, Bing Chen, Angèle Bénard, Gordon Dougan, Daisy W Leung, Gaya K Amarasinghe, John Chan, Christopher F Basler, William R Jacobs, JoAnn M Tufariello
Multiple genetic paths including massive gene amplification allow Mycobacterium tuberculosis to overcome loss of ESX-3 secretion system substrates. Proceedings of the National Academy of Sciences of the United States of America 119 (8) (2022)
Catherine Vilchèze, William R Jacobs
The promises and limitations of N-acetylcysteine as a potentiator of first-line and second-line tuberculosis drugs. Antimicrobial agents and chemotherapy (2021)
Clare Burn Aschner, Lip Nam Loh, Benjamin T Galen, Isabel Delwel, Rohit K Jangra, Scott J Garforth, Kartik Chandran, Steven Almo, William R Jacobs, Carl F Ware, Betsy C Herold
HVEM signaling promotes protective antibody-dependent cellular cytotoxicity (ADCC) vaccine responses to herpes simplex viruses. Science immunology 5 (50) (2021)
Katherine Kaugars, Joseph Dardick, Anna Paula de Oliveira, Kayla A Weiss, Regy Lukose, John Kim, Lawrence Leung, Saranathan Rajagopalan, Sydney Wolin, Leor Akabas, David M Knipe, Goran Bajic, William R Jacobs
A recombinant herpes virus expressing influenza hemagglutinin confers protection and induces antibody-dependent cellular cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America 118 (34) (2021)
Catherine Vilchèze, Steven A Porcelli, John Chan, William R Jacobs
Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis. mBio 12 (1) (2021)
Tony W Ng, Ariel S Wirchnianski, Anna Z Wec, J Maximilian Fels, Christopher T Johndrow, Kevin O Saunders, Hua-Xin Liao, John Chan, William R Jacobs, Kartik Chandran, Steven A Porcelli
Exploiting Pre-Existing CD4+ T Cell Help from Bacille Calmette-Guérin Vaccination to Improve Antiviral Antibody Responses. Journal of immunology (Baltimore, Md. : 1950) 205 (2) (2020)
Samuel J Modlin, Derek Conkle-Gutierrez, Calvin Kim, Scott N Mitchell, Christopher Morrissey, Brian C Weinrick, William R Jacobs, Sarah M Ramirez-Busby, Sven E Hoffner, Faramarz Valafar
Drivers and sites of diversity in the DNA adenine methylomes of 93 Mycobacterium tuberculosis complex clinical isolates. eLife 9 (2020)
Rebecca A Luchtel, Tushar Bhagat, Kith Pradhan, William R Jacobs, Mark Levine, Amit Verma, Niraj K Shenoy
High-dose ascorbic acid synergizes with anti-PD1 in a lymphoma mouse model. Proceedings of the National Academy of Sciences of the United States of America 117 (3) (2020)
Suzanne M Hingley-Wilson, Nan Ma, Yin Hu, Rosalyn Casey, Anders Bramming, Richard J Curry, Hongying Lilian Tang, Huihai Wu, Rachel E Butler, William R Jacobs, Andrea Rocco, Johnjoe McFadden
Loss of phenotypic inheritance associated with ydcI mutation leads to increased frequency of small, slow persisters in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America 117 (8) (2020)
Paras Jain, Spencer Garing, Deepshikha Verma, Rajagopalan Saranathan, Nicholas Clute-Reinig, Jacob Gadwa, Chelsea Peterson, Gleda Hermansky, Anna Astashkina Fernandez, Emmanuel Asare, Torin R Weisbrod, Ethan Spencer, Claire V Mulholland, Michael Berney, David Bell, Kevin P Nichols, Anne-Laure M Le Ny, Diane Ordway, William R Jacobs, Akos Somoskovi, Kyle J Minch
Nanoluciferase Reporter Mycobacteriophage for Sensitive and Rapid Detection of Mycobacterium tuberculosis Drug Susceptibility. Journal of bacteriology 202 (22) (2020)
Catherine Vilchèze, Rajagopalan Saranathan, Brian Weinrick, William R Jacobs
Characterization of Large Deletion Mutants of Mycobacterium tuberculosis Selected for Isoniazid Resistance. Antimicrobial agents and chemotherapy 64 (9) (2020)

William R Jacobs.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

William R Jacobs